• LAST PRICE
    0.0045
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    --- / 0.0045
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    High 0.0090
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesETBI
Eastgate Biotech Corp
3.2M
-0.9x
---
United StatesPBM
Psyence Biomedical Ltd
3.0M
-1.0x
---
United StatesPCSA
Processa Pharmaceuticals Inc
2.9M
-0.2x
---
United StatesTTNP
Titan Pharmaceuticals Inc
3.6M
-0.5x
---
United StatesCSUI
Cannabis Suisse Corp
1.6M
-0.8x
---
United StatesPRFX
PainReform Ltd
1.9M
0.0x
---
As of 2024-11-22

Company Information

EastGate Biotech Corp. is a biotechnology company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. The Company utilizes nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company also develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). Its E-Drops NANO is used to combat urinary and vaginal tract infections.

Contact Information

Headquarters
2203-65 Harbour SquareTORONTO, ON, Canada M5J 2L4
Phone
801-322-3401
Fax
---

Executives

President, Treasurer, Secretary, Director
Rose Perri
Chief Executive Officer, Director
Anna Gluskin
Chief Operating Officer
Bill Abajian

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.2M
Revenue (TTM)
$137.6K
Shares Outstanding
717.3M
Eastgate Biotech Corp does not pay a dividend.
Beta
---
EPS
$-0.01
Book Value
$-0.01
P/E Ratio
-0.9x
Price/Sales (TTM)
23.5
Price/Cash Flow (TTM)
---
Operating Margin
-2,600.25%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.